Email
Password
Remember meForgot password?
    Log in with Twitter

Pharmaceuticals News

CMOs at front of biopharmaceutical manufacturing technology

Contract manufacturing organizations are on the leading edge of new pharmaceutical manufacturing technology adoption, according to a new overview of the sector.

Bleak perceptions of Brexit for British business

London - A number of British business are getting nervous about the Brexit process. Airbus, BMW and Siemens have each warned about the impact on their U.K.-based operations if the U.K. leaves the EU in March 2019 without any agreement.

Russia also threatens retaliation as tariff war heats up

Russia is the latest country to threaten retaliation against U.S. tariffs imposed on steel and aluminum imports, warning on Friday that American cars could soon face higher taxes.

Risk assessment is central to making pharmaceuticals Special

Portmarnock - The manufacture of pharmaceuticals, and an evaluation of microbial hazards, requires a scientific approach to risk assessment. This was the key message from the recent Pharmig meeting on Quality Risk Management.

Amazon drops plan to sell bulk pharmaceuticals

Amazon Business, which is the bulk products arm of Amazon, appears to be dropping its plan to become a major distributor of pharmaceutical and medical devices products. This follows on from indications last year that Amazon was to enter the fray.

How artificial intelligence is influencing drug discovery

The drive for new medications addresses patient need and is the motor that keeps the pharmaceutical sector turning. To accelerate the drug discovery process, pharmaceutical organizations are turning to artificial intelligence.

Op-Ed: Curing patients not good for business — Goldman Sachs

New York City - The company famous for its social sensitivity has decided that curing sick people simply reduces profits. Goldman Sachs, with a degree of insensitivity or perhaps just more grovelling to the rich, has come up with reasons for people to stay sick.

Pharmaceuticals set for digital disruption

Digital transformation has affected many sectors of the economy, and this includes healthcare and related activities, such as new technologies. A new report signals some major changes coming for pharmaceuticals.

Applying e-learning to pharma and healthcare: Interview Special

E-learning carries many advantages for companies, including delivering training remotely and with minimum disruption. One area of increased take-up is pharma. To understand how such training can be delivered, Laura Guardi of Pharmig explains.

Merck & Co. shows how a company can go digital

Pharmaceutical companies are under pressure to reduce expenses while improving results. This is one reason why the sector is looking towards digital technologies. A company down this journey is life science business Merck & Co.

Road map for the digital transformation of pharmaceuticals

Berlin - The impact and future of digitization along the value chain of the pharmaceutical industry have been discussed at a recent conference. The process of digital transformation presents both opportunities and threats for pharma.

Digital transformation underway with bioprocessing

Industry 4.0, especially the approaches of cyber-physical systems control and monitor activity through computer-based algorithms, are impacting on the bioprocessing sector as pharmaceuticals seek improved efficiencies.

Brexit uncertainty for pharmaceutical companies

Of the different sectors of the British economy affected by the U.K.’s impending exit from the European Union, the pharmaceutical sector is one of the most significant. This relates to the value of the market and the regulatory impact.

Why the pharmaceuticals sector is adopting single-use technology

A new paradigm is taking place in the world of pharmaceuticals, with a shift away from re-used, re-washed and re-sterilized equipment and eastwards the adoption of single-use sterile systems.

Disruptions in store for pharmaceuticals in 2018

New technologies, cloud computing, and wider use of risk assessment are among the continuing changes that are disrupting the pharmaceutical sector. Expect 2018 to see the pace of change to accelerate.

Rapid methods needed to help safety of medicines Special

Oxford - Pharmaceutical organizations need to embrace rapid methods in order to protect patients, obtain faster results, and help to address inventory issues. This was a key message delivered at the annual Pharmig conference.

Rebuilding the pharmacy from shop to digital: Interview Special

Washington - CaryRx is a pharmacy startup that has set out to rebuild the pharmacy concept from the ground up, through the use of a mobile app. To hear more about this next generation approach to pharmacies we spoke with company co-founder Areo Nazari.

Why data integrity is essential for the pharmaceutical sector Special

Otocec - Data integrity is necessary for ensuring the safety of medicine, helping to assure that release tests are correct and have not been corrupted. This was a key message at a recent Pharmig conference held in Slovenia.

Digital healthcare requires new workforce skills and strategy

Digital healthcare represents a fast-moving field. However, as a new survey indicates, job skills are creating unevenness within the field — and problems for the industry overall.

Digital health technology needs to be patient-centric

The next wave of digital health technology needs to focus on the patient experience, either in the way patients interact with technology or the way the use it. This is a key finding from a new report into the state of pharmaceuticals and healthcare.

Benchmarking the adoption of digital health technology

The tenth PwC report into the ‘digital health IQ’ of looks at the state of companies operating in the pharmaceutical and life sciences sector and it shows a faster, although sometimes uneven, rate of adoption of healthcare technology.

Screening for novel drugs using powerful computers

London - Searching for new types of drugs is a medical imperative. This is a complex task involving many types of diseases and chemical interactions. To assist with this process, Francis Crick Institute researchers have developed a new model.

Blockchain-powered supply chain tracker

When it comes to supply chain practices, pharmaceuticals must address the normal concerns of customer satisfaction and the control goods as well as strict regulatory requirements. To better produce medicines, a new high-tech sensor has been developed.

Pharmaceutical sector is waking up to big data

Pharmaceutical companies are showing an increased interest in big data, focused on areas like drug discovery and with a realization this can give them a competitive advantage. This might not come so easily, however, without a joined-up strategy.

Pharmaceuticals facing up to data integrity concerns

Pharmaceutical organizations are increasingly reliant upon automated systems and computers, from manufacturing to laboratory release testing. This has brought a renewed regulatory focus on the subject of data integrity.

Pharmaceutical cleaning validation simplified with new software

Washington - The company Quascenta has simplified cleaning validation for active pharmaceutical ingredient manufacturers through a new software package called eResidue. Cleaning validation is a key process, and it avoids cross-contamination.

Old drug sheds a new light on autism

University of California San Diego School of Medicine have completed an early phase clinical trial to evaluate the effectiveness of an established drug for the treatment of autism.

Herbal coffee recalled due to erectile dysfunction additive

Bethesda - A brand of herbal coffee has been recalled from the market after it was discovered that the product contained an unintended active pharmaceutical ingredient, designed to control erectile dysfunction.

Microbiologists assess ways to lower medicine contamination risks Special

Dublin - Microbiologists from a range of pharmaceutical and healthcare companies convened in Dublin to attend a conference discussing how to effectively monitor the built environment for risks in relation to drug product manufacturing.

Microbiologists review best practices for making medicines Special

Birmingham - The manufacture of medicines is at risk from cross-contamination from people, a result of the shedding of microorganisms. In February a special two-day conference considered how best to manage this risk.
  1 2 3 4 Next»

Set up a news alert for

Pharmaceuticals


Pharmaceuticals Image

Medicine vials on display at making Pharmaceuticals 2015.
Medicine vials on display at making Pharmaceuticals 2015.
Project Team at work:  Expertise helps AbbVie develop and enhance products and therapies to treat co...
Project Team at work: Expertise helps AbbVie develop and enhance products and therapies to treat conditions including HIV, arthritis, immunological and metabolic disorders, heart disease, and cancer.
© AbbVie Inc.
Sativex contains marijuana-derived ingredients.
Sativex contains marijuana-derived ingredients.
Associated Press
Untitled
Grumpy-Puddin
Dr. Olumayokun Olajide s research will now look to produce compound derivatives of punicalagin for a...
Dr. Olumayokun Olajide's research will now look to produce compound derivatives of punicalagin for a drug that would treat neuro-inflammation, slowing down the progression of Alzheimer's
University of Huddersfield
Pharmaceutical manufacturing at BPL  Elstree  UK.
Pharmaceutical manufacturing at BPL, Elstree, UK.
Eli Lilly s global headquarters  Indianapolis  Indiana
Eli Lilly's global headquarters, Indianapolis, Indiana
Guanaco152003
A variety of statin drugs
A variety of statin drugs
Biogen is an American global biotechnology company based in Cambridge  Massachusetts  specializing i...
Biogen is an American global biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases to patients worldwide.
Biogen
U.S. drug company sues Canada for trying to lower cost of $700K-a-year drug
U.S. drug company sues Canada for trying to lower cost of $700K-a-year drug
Alexion Pharmaceuticals